1. Genetic diversity of dengue virus circulating in the Philippines (2014–2019) and comparison with dengue vaccine strains.
- Author
-
Velasco, John Mark, Klungthong, Chonticha, Chinnawirotpisan, Piyawan, Diones, Paula Corazon, Valderama, Maria Theresa, Leonardia, Susie, Manasatienkij, Wudtichai, Joonlasak, Khajohn, Rodpradit, Prinyada, Mateo, Jennifer, Vila II, Vicente, Navarro, Fatima Claire, Jones, Anthony, Farmer, Aaron, and Fernandez, Stefan
- Subjects
- *
DENGUE viruses , *WHOLE genome sequencing , *GENETIC variation , *VACCINE development , *VIRUS diversity - Abstract
Dengue virus has four distinct serotypes and the genetic diversity within each of the four serotypes contribute to its complexity. An important aspect of dengue molecular evolutionary studies has been the dissection of the extent and structure of genetic variation among major genotypes within each serotype. It is important to understand the role of dengue genetic variability and its potential role and impact in the effectiveness of the dengue vaccine. Demographic data and blood were collected from patients seen at a tertiary hospital in the Philippines and clinically diagnosed with dengue from 2014–2019. Dengue virus (DENV) RT-PCR was used to confirm infection and positive samples underwent whole genome sequencing. Phylogenetic analysis was performed on 127 samples (25 DENV-1, 19 DENV-2, 70 DENV-3, and 13 DENV-4). We observed a serotype shift in 2014 and 2022. We detected the following genotypes per serotype for the wild-type (WT) DENV sequences: genotype IV (DENV-1), cosmopolitan (DENV-2), genotype I (DENV-3) and genotype IIa (DENV-4). WT DENV belonged to different genotypes versus the QDENGA strains and except for DENV-4, belonged to different genotypes versus the Dengvaxia strains. Comparing Dengvaxia vaccine sequences with WT DENV, we observed 23, 24, 34, and 9 positions with amino acid changes in the entire envelope protein, with 1, 5, 1, and 2 positions with amino acid changes identified among the important human monoclonal antibodies (mAbs) targeted epitope positions. We detected 24, 25, 36 and 12 positions with amino acid changes in the E protein with 0, 5, 1, and 2 positions with amino acid changes among the important mAbs targeted epitope positions for DENV-1, DENV-2, DENV-3, and DENV-4, respectively when comparing QDENGA vaccine sequences with the WT DENV. We showed low genotype complexity, genetically distinct clades and local evolution for DENV circulating in the Philippines. Author summary: Dengue virus has four distinct serotypes and each serotype is further divided into distinct genotypes. There are currently two licensed dengue vaccines, Dengvaxia and QDENGA and we compared the genotypes of the circulating wild type (WT) dengue viruses (DENV) versus the genotypes of the strains of the two dengue vaccines. We also analyzed whether there were any amino acid changes in selected locations which have been previously identified as targets by potent virus neutralizing human monoclonal antibodies (mAbs) which are considered important in vaccine development. We collected blood from patients diagnosed with dengue from 2014 to 2019 from the Philippines and sequenced the dengue RT-PCR positive samples. WT DENV all belonged to different genotypes versus the QDENGA vaccine and except for DENV-4, belonged to different genotypes versus the Dengvaxia strains. We detected several amino acid changes in the dengue envelope protein and in particular, among important mAbs targeted epitope positions among the 4 serotypes when we compared QDENGA and Dengvaxia vaccine sequences with WT DENV sequences. We observed that the DENV genotypes circulating in the Philippines from 2014–2019 had low complexity and the circulating clades were genetically distinct. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF